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Abstract
YAP (Yes-associated protein) is a transcription co-activator in the Hippo tumor suppressor 
pathway and controls cell growth, tissue homeostasis, and organ size. YAP is inhibited by the 
kinase Lats, which phosphorylates YAP to induce its cytoplasmic localization and proteasomal 
degradation. YAP induces gene expression by binding to the TEAD family transcription factors. 
Dysregulation of the Hippo-YAP pathway is frequently observed in human cancers. Here we show 
that cellular energy stress induces YAP phosphorylation, in part due to AMPK-dependent Lats 
activation, thereby inhibiting YAP activity. Moreover, AMPK directly phosphorylates YAP S94, a 
residue essential for the interaction with TEAD, thus disrupting the YAP-TEAD interaction. 
AMPK-induced YAP inhibition can suppress oncogenic transformation of Lats-null cells with 
high YAP activity. Our study establishes a molecular mechanism and functional significance of 
AMPK in linking cellular energy status to the Hippo-YAP pathway.
INTRODUCTION
The Hippo pathway was originally discovered in Drosophila1 to regulate organ size and is 
highly conserved in higher eukaryotes2. Core components of the mammalian Hippo pathway 
include MST1/2 and Lats1/2 kinases and their downstream effectors, YAP and TAZ 
transcription co-activators3. In response to unfavorable growth conditions, MST1/2 
phosphorylate and activate Lats1/2, which in turn phosphorylate and inhibit YAP/TAZ. The 
Lats-dependent phosphorylation of YAP/TAZ promotes their binding to 14-3-3, resulting in 
cytoplasmic localization and functional inactivation4–6. Moreover, phosphorylated 
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YAP/TAZ are targeted for ubiquitination and degradation7, 8. The Hippo pathway thus 
suppresses tumorigenesis by limiting the activity of YAP/TAZ9–11. YAP/TAZ activity must 
be strictly regulated for tissue/organs to reach and maintain proper size2, 3, 12–14. YAP/TAZ 
can promote cell proliferation and inhibit apoptosis; abnormal activation of YAP/TAZ is 
frequently found in human cancers15, 16. However, the function of YAP in human cancer is 
complex and could be cell-type-dependent. For instance, YAP could function as a tumor 
suppressor in some cell types, such as hematological cancers, by inducing apoptosis in 
response to DNA damage17–19.
Recent studies have revealed a large number of extra- and intracellular signals that modulate 
YAP/TAZ activity. For example, cell density/cell contact strongly suppresses YAP activity 
concomitantly with increased Lats kinase activity4, which may be mediated by tight 
junctions and adherent junctions20, 21. Diffusible hormones, such as lysophosphatidic acid 
and epinephrine acutely regulate YAP activity (either stimulatory or inhibitory) via G-
protein coupled receptor (GPCR)22–25. Furthermore, mechanic stress has been shown to 
regulate YAP activity26–28. These signals might all act through alteration of actin dynamics 
to modulate Lats kinase activity and YAP function.
In this study, we discovered that YAP is inhibited by cellular energy stress. AMPK is a key 
cellular energy sensor activated by increasing AMP levels and functions to coordinate cell 
growth with energy availability. We show that AMPK can inhibit YAP by two mechanisms: 
directly via phosphorylation of YAP S94, and indirectly via activation of the Lats kinase. 
This work therefore reveals molecular insights of Hippo-YAP regulation by cellular energy 
status.
RESULTS
Cellular energy starvation induces YAP phosphorylation and inactivation
Cell growth is an energy-consuming process and must be coordinated with cellular energy 
status. Given the key function of YAP in cell growth regulation, we investigated whether 
YAP is regulated by energy stress. Glucose starvation strongly induced YAP 
phosphorylation as determined by mobility shift on a phos-tag gel (Fig. 1a). Previous studies 
have shown that Lats phosphorylates YAP on five serine residues and phosphorylation of 
S127 is critical for the interaction between YAP and 14-3-3, which sequesters YAP in the 
cytoplasm4. Glucose starvation induced YAP S127 phosphorylation (Fig. 1a), suggesting 
that cellular energy stress inhibits YAP. AMPK is a key cellular energy sensor. As expected, 
glucose starvation activated AMPK as indicated by the increased phosphorylation of the 
activation loop T172 in AMPKα (Fig. 1a)29. 2-deoxy-D-glucose (2-DG) is a 
nonmetabolizable glucose analog that can inhibit normal glucose metabolism therefore 
inducing cellular energy stress. Addition of 2-DG activated AMPK as indicated by the 
increased phosphorylation of acetyl-CoA Carboxylase (ACC), an AMPK substrate, and also 
induced YAP phosphorylation (Fig. 1b). The effect of 2-DG on YAP phosphorylation was 
more robust in low-glucose conditions. We tested YAP phosphorylation using a similar 
concentration of sorbitol and found that the effect of 2-DG was specific, excluding a 
possible osmotic effect (Supplementary Fig.1a). 2-DG increased the phosphorylation of 
AMPKα and YAP in a dose- and time dependent manner (Supplementary Fig. 1b, c). 
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Notably, 2-DG also induced a TAZ mobility shift, indicating that 2-DG also increased TAZ 
phosphorylation. It is worth noting that ACC phosphorylation was more sensitive to 2-DG 
treatment than YAP phosphorylation (Fig.1b), consistent with the distinct cellular functions 
of ACC (fatty acid synthesis and energy storage) and YAP (cell growth and survival). One 
may speculate that fatty acid synthesis should be inhibited prior to growth inhibition and 
apoptosis. Thus, ACC could be inhibited under mild energy stress whereas more severe 
energy stress is required to inhibit YAP. Energy stress-induced YAP phosphorylation was 
also observed in myoblast C2C12, mammary epithelial MCF10A, and the cervical cancer 
HeLa cell lines (Supplementary Fig. 1d–f).
A major role of YAP phosphorylation is to promote its cytoplasmic sequestration4. 
Immunofluorescence staining of endogenous YAP revealed that 2-DG treatment decreased 
nuclear and increased cytoplasmic YAP staining (Fig. 1c). Numerous transcription factors 
have been implicated to be YAP targets; in particular, the TEAD family has been most 
convincingly shown to mediate biological functions of YAP12, 13, 30–32. Consistent with the 
cytoplasmic YAP localization, 2-DG blocked the interaction between YAP and TEAD (Fig. 
1d). Glucose starvation also diminished YAP-TEAD interaction (Supplementary Fig. 1g). 
These observations link cellular energy stress to YAP inhibition. To further confirm the 
negative regulation of YAP by cellular energy stress, we measured YAP target gene 
expression and found that 2-DG treatment significantly decreased the expression of TEAD 
target genes, CTGF and CYR61 (Fig. 1e)3. Collectively our data suggest that cellular energy 
stress inhibits YAP and TAZ activity.
Energy stress activates Lats kinase
The increase of YAP S127 phosphorylation indicates that Lats kinase activity is enhanced 
by energy stress (Fig. 1a). Phosphorylation of S909 and T1079 in Lats1 positively correlate 
with Lats activity33, 34. We therefore monitored S909 and T1079 phosphorylation in 
endogenous Lats1 in response to energy stress. 2-DG treatment significantly increased 
phosphorylation of both residues in immunoprecipitated Lats1 (Fig. 1f). In addition, we 
directly measured Lats1 kinase activity through an in vitro kinase assay using recombinant 
YAP as a substrate. Lats1 immunoprecipitated from glucose-starved HEK293A cells 
displayed a significantly higher kinase activity towards YAP (Fig. 1g). Next, we 
investigated the function of MST in energy stress-induced YAP phosphorylation. 
Overexpression of wild-type MST2 had a minor effect on 2-DG-induced YAP 
phosphorylation whereas the MST2 kinase-inactive (MST2-KR) mutant partially blocked 
the YAP mobility shift (Supplementary Fig. 2a). However, 2-DG did not activate MST, as 
the activation loop phosphorylation of MST (T183) was not increased (Supplementary Fig. 
2b). Thus, we conclude that cellular energy stress activates Lats activity and promotes YAP 
phosphorylation and inhibition which might have a role in cell growth suppression in 
response to energy starvation.
AMPK is required for energy starvation-induced YAP phosphorylation
AMPK directly monitors cellular ATP and AMP levels and regulates cell metabolism and 
growth in response to cellular energy status29. We investigated the role of AMPK in YAP 
regulation by comparing AMPKα wild-type (WT) and AMPKα α double-knockout (DKO) 
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mouse embryonic fibroblasts (MEFs) that lack the two AMPK catalytic alpha subunits 
(Supplementary Fig. 3a). Notably, 2-DG treatment failed to induce YAP mobility shift in the 
AMPKα DKO MEFs, indicating a critical role of AMPKα in YAP regulation by energy 
stress (Fig. 2a). Treatment with lambda phosphatase (λ-PPase) abolished the 2-DG-induced 
YAP mobility shift (Supplementary Fig. 3b). These data indicate that cellular energy stress 
induces YAP phosphorylation in an AMPK-dependent manner.
We next determined whether AMPK is sufficient to induce YAP phosphorylation. 
Expression of WT AMPKα1 or AMPKα2, but not the DN mutant, induced significant YAP 
phosphorylation as indicated by the altered mobility shift on a phos-tag gel (Fig. 2b), 
suggesting that AMPK can induce YAP phosphorylation. Moreover, 2-DG could activate 
Lats1 in AMPKα WT MEFs, but 2-DG-induced Lats phosphorylation was partially 
compromised in the AMPKα DKO MEFs (Fig. 2c). These data suggest that AMPK relays, 
at least partly, the energy stress signal to Lats activation. Consistent with a role in YAP 
inhibition, we confirmed that AMPK co-transfection disrupted the YAP-TEAD interaction 
(Fig. 2d) and suppressed TEAD-luciferase reporter activity (Fig. 2e). Furthermore, the 
AMPK-DN increased reporter activity, consistent with the notion that AMPK-DN interferes 
with endogenous AMPK function in a dominant-negative fashion‥
Metformin, a widely prescribed drug for type II diabetes35, activates AMPK, inhibits cell 
growth and reduces tumor incidence36, 37. Most in vitro studies use doses of metformin 
significantly higher than the therapeutic levels of plasma metformin 38. We found that 
metformin treatment increased AMPK activity and YAP phosphorylation (Fig. 2f). 
Metformin also increased TAZ phosphorylation. Aminoimidazole carboxamide 
ribonucleotide (AICAR) is a well-known AMPK activator 29. Similar to metformin, AICAR 
induced YAP and TAZ phosphorylation (Supplementary Fig. 3c). YAP S127 
phosphorylation was decreased by AICAR treatment, indicating a possible disconnection 
between AMPK activation and Lats activation under this condition. A YAP-TEAD co-
immunoprecipitation experiment revealed that AICAR reduced the interaction between YAP 
and TEAD (Fig. 2g). Metformin and AICAR treatments also decreased the expression of 
YAP-TEAD target genes Ctgf and Cyr61 (Fig. 2h). The stronger inhibitory effects of 
AICAR on YAP target genes are consistent with the fact that AICAR induced a strong YAP 
phosphorylation (Supplementary Fig. 3c, d). Another AMPK activator, A76966239, also 
stimulated YAP phosphorylation in HepG2 cells (Supplementary Fig. 3e). Collectively, our 
data show that pharmacological activation of AMPK leads to YAP phosphorylation and 
inhibition, demonstrating a general role of AMPK in YAP regulation.
Energy stress induces both Lats-dependent and -independent YAP phosphorylation
Lats is the major kinase responsible for YAP/TAZ inhibition, although other kinases have 
also been implicated in their regulation20, 40, 41. To confirm the role of Lats in energy stress-
induced YAP phosphorylation, we compared the Lats1−/−;Lats2fl/fl (Lats1 KO) MEFs with 
the Lats1/2−/− (Lats1/2 DKO) MEFs42 generated by infection of the Cre virus in the 
Lats1−/−;Lats2fl/fl (Lats1 KO) MEFs. As expected, deletion of Lats1/2 completely abolished 
YAP S127 phosphorylation and increased YAP protein levels (Fig. 3a). Moreover, the 2-
DG-induced YAP mobility shift was significantly diminished in Lats1/2 DKO MEFs, 
Mo et al. Page 4
Nat Cell Biol. Author manuscript; available in PMC 2015 October 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
supporting a role of Lats in energy-stress-induced YAP phosphorylation. However, 2-DG 
still induced a visible YAP mobility shift in the Lats1/2 DKO cells (Fig. 3a), suggesting that 
2-DG could induce YAP phosphorylation independent of Lats. Interestingly, AMPK 
activation was noticeably enhanced in the Lats1/2 DKO MEFs compared to Lats1 KO MEFs 
(Fig. 3a). The enhanced AMPK activation in the Lats1/2 DKO MEFs indicates that these 
cells are under more severe energy stress. This phenomenon can be explained by a model in 
which the high YAP activity in the Lats1/2 DKO cells promotes cell growth and increases 
energy expenditure, thereby reading to energy stress in these cells.
We further investigated the function of Lats in energy stress-induced YAP phosphorylation. 
Co-transfection of Lats2 increased basal YAP phosphorylation, whereas the Lats2 kinase-
inactive (Lats2-KR) mutant blocked YAP phosphorylation (Fig. 3b). Interestingly, Lats2-
KR did not completely block 2-DG-induced YAP mobility shift although it strongly reduced 
2-DG-induced YAP-S127 phosphorylation, suggesting that 2-DG could also induce Lats-
independent phosphorylation of YAP, consistent with the observation in Fig. 3a.
We used the YAP-5SA mutant, which lacks the five known Lats phosphorylation consensus 
serine residues (including S61, S119, S127, S164, and S381)13 to investigate the AMPK-
dependent but Lats-independent YAP phosphorylation. Transfection of AMPKα, but not the 
AMPKα DN mutant, induced a mobility shift of the YAP-5SA mutant (Fig. 3c), indicating 
that AMPK can promote Lats-independent YAP phosphorylation. Energy stress increases 
the interaction between AMPK and its physiological substrates43–45; accordingly, AMPK 
co-precipitated with YAP and this interaction was further enhanced by 2-DG treatment (Fig. 
3d, e). Moreover, the AMPK activators AICAR and metformin increased the association of 
endogenous YAP and AMPK (Fig. 3f). Although the precise molecular basis for the energy-
stress-induced interaction between AMPK and YAP is unknown, our data suggest a direct 
role of AMPK in YAP phosphorylation.
AMPK inhibits YAP by directly phosphorylating serine 94
To gain mechanistic insight into AMPK-mediated regulation of YAP, we tested whether 
YAP is a direct substrate of AMPK. AMPK phosphorylated recombinant YAP-WT in vitro 
(Fig. 4a). The YAP-S127A and YAP-5SA mutants were also phosphorylated by AMPK, 
though more weakly, indicating that AMPK can phosphorylate YAP on residues distinct 
from the Lats phosphorylation sites. In vitro phosphorylation by AMPK altered the 
migration of YAP-5SA (Supplementary Fig. 4a). Mass spectrometry experiments of several 
batches of in vitro phosphorylated YAP-5SA identified several phosphorylation sites on 
YAP, including high- and low-confidence sites (Supplementary Fig. 4b). Further in vitro 
phosphorylation experiments confirmed that serine residues 94, 366 and 463 were direct 
AMPK targets (Fig. 4b and Supplementary 4c). We examined the robustness of YAP as an 
AMPK substrate by comparing with known physiological AMPK substrates TSC2 and 
ULK143, 44. AMPK phosphorylated YAP as efficiently as ULK1 (Supplementary Fig. 4d–f); 
the efficiency of YAP (51–270) phosphorylation by AMPK was comparable with the TSC2 
fragment (1300–1367). Because energy starvation or AMPK co-transfection inhibits YAP 
transcriptional activity (Fig.1d, 2d, 2e), we examined the effect of the putative AMPK 
phosphorylation sites on YAP activity. Mutation of YAP S94 to glutamate or alanine 
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diminished the ability of YAP to activate the TEAD1 reporter, whereas mutation of S366 or 
S463 did not significantly affect YAP activity (Fig. 5a, b). Therefore, we focused our further 
studies on S94. Notably, substitution of S94 by any residue, including alanine or glutamate, 
abolished YAP-TEAD interaction (Fig. 5c) and decreased TEAD reporter activity. We 
propose that phosphorylation of YAP-S94 by AMPK disrupts its interaction with TEAD.
Identification of YAP-S94 as an AMPK phosphorylation site is exciting because our 
previous studies had demonstrated that YAP-S94 is directly involved in and is essential for 
the interaction with TEAD46. Based on the YAP-TEAD co-crystal structure, YAP-S94 
forms a hydrogen bond with Y406 in TEAD46, 47. Notably, S94 is functionally conserved 
from drosophila Yki to mammalian YAP/TAZ and is also predicted to be phosphorylated by 
PhosphoSite (http://www.phosphosite.org). However, AMPK co-transfection did not inhibit 
the interaction between YAP and RUNX2 (Supplementary Fig. 4g), suggesting a specific 
role of S94 phosphorylation in regulating the interaction with TEAD. These observations 
collectively suggest that AMPK could inhibit YAP function by phosphorylating S94 and 
disrupting its interaction with TEAD.
We generated a phospho-YAP (S94) specific antibody and confirmed that it selectively 
recognized in vitro phosphorylated YAP, but not unphosphorylated or the S94A mutant of 
YAP (Fig. 5d). As expected, AMPK transfection or activation of AMPK by AICAR 
increased YAP S94 phosphorylation (Fig. 5e, 5f). Collectively, our data indicate that AMPK 
directly phosphorylates YAP on S94 in vivo in response to energy stress.
Energy stress inhibits the oncogenic potential of Lats1/2 DKO cells
To further substantiate the Lats-independent regulation of YAP, we measured the expression 
of YAP target genes in Lats1/2 DKO MEFs. AICAR could still repress the YAP target 
genes Ctgf and Cyr61, supporting Lats-independent YAP inhibition by energy stress (Fig. 
6a). We next examined the role of such Lats-independent YAP inhibition in oncogenic 
transformation. Lats1/2 DKO MEFs could form colonies in soft agar, an indication of 
oncogenic transformation (Fig. 6b). YAP/TAZ knockdown blocked the anchorage-
independent growth of the Lats1/2 DKO MEFs, suggesting that YAP/TAZ are required for 
the transforming potential of these cells. Based on our model, AMPK could inhibit YAP in 
the Lats1/2 DKO MEFs by phosphorylating S94, therefore should suppress the anchorage-
independent growth of Lats1/2 DKO MEFs. Indeed, treatment with AICAR or metformin 
inhibited anchorage-independent growth of Lats1/2 DKO MEFs in vitro (Fig. 6c). In an 
immunocompromised nude mouse xenograft model, injection of Lats1/2 DKO MEFs 
resulted in tumor development (Fig. 6d). Consistent with the cell culture results, metformin 
injection significantly reduced xenografted tumor growth in these mice. Collectively, these 
data support a model that AMPK could inhibit YAP in vivo in the absence of Lats1/2.
AMPK is required for YAP inhibition by energy stress
To demonstrate that AMPK mediates the effect of AICAR on YAP inhibition, AMPK was 
knockdown by siRNA in Lats1/2 DKO MEFs. Knockdown efficiency was confirmed by 
Western blot (Fig. 7a). Depletion of AMPK blocked the inhibitory effect of AICAR or 
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A769662 on YAP target gene expression (Fig. 7a and 7b). These results further support that 
AMPK is involved in YAP inhibition in the Lats1/2 DKO MEFs upon energy stress.
It is possible that AICAR reduced Ctgf/Cyr61 expression and anchorage-independent 
growth of Lats1/2 DKO MEFs by inhibiting factors other than YAP. Therefore, we tested 
whether AICAR- or metformin-induced YAP inhibition is important to achieve their tumor-
suppressive effects in Lats1/2 DKO MEFs. We generated a YAP construct resistant to 
AMPK inhibition by fusing the C-terminal transactivation domain of YAP(AD) to TEAD1 
fragment residues 1–289, which contains only the DNA binding domain. The TEAD1ΔC-
YAP(AD) fusion should be constitutively active and not inhibited by AMPK. When the 
TEAD1ΔC–YAP(AD) plasmid was expressed in Lats1/2 DKO MEFs, mRNA levels of Ctgf 
and Cyr61 were not significantly increased, suggesting that activity of the ectopic 
TEAD1ΔC-YAP(AD) was not significantly higher than the fully activated endogenous 
YAP/TAZ in the LATS1/2 DKO cells (Fig. 7c). Interestingly, AICAR inhibited the 
expression of Ctgf and Cyr61 in the vector-transfected cells, but not the TEAD1ΔC-
YAP(AD)-expressing cells. Furthermore, AICAR, metformin, and A769662 could not 
suppress the anchorage-independent growth of the TEAD1ΔC-YAP(AD)-expressing cells, 
although they suppressed the control group Lats1/2 DKO MEFs (Fig. 7d). These data 
support a notion that activation of AMPK inhibits the anchorage-independent growth of the 
Lats1/2 DKO MEFs by suppressing YAP/TAZ activity.
Discussion
Extensive studies have revealed that the Hippo-YAP signalling is regulated by a variety of 
extracellular signals48. These include cell-cell contact signals (such as tight junctions and 
adherent junctions), physical signals (such as mechanical stress and matrix stiffness), and 
long-range hormonal signals (such as lysophosphatidic acid and epinephrine). In this study, 
we show that intracellular metabolic/energy status also regulates Lats and YAP activity. 
Therefore, the Hippo-YAP pathway can integrate and coordinate both extracellular and 
intracellular signals.
Cellular energy stress is detected by AMPK, which modulates cellular metabolism and 
limits cell growth29. Our data show that energy stress inhibits YAP via two mechanisms, 
Lats-dependent and Lats-independent (Fig. 6e). In the former, AMPK may indirectly 
activate Lats in response to energy stress. Consistently, a recent report has shown that 
AMPK phosphorylates and stabilizes angiomotin (AMOTL1) to stimulate Lats activity 49. 
The Lats-independent mechanism of YAP inhibition is achieved via direct AMPK-mediated 
phosphorylation of YAP. S94 phosphorylation by AMPK plays a critical role in YAP 
inhibition by disrupting the YAP-TEAD complex, leading to repression of YAP target genes 
and inhibition of cell growth. Our previous biochemical and structural studies have defined 
an essential function of S94 in YAP-TEAD complex formation by forming a hydrogen bond 
with Y406 in TEAD146. S94 is conserved in TAZ and mutation of the corresponding S51 in 
TAZ also abolished TAZ-TEAD interaction50. Moreover, YAP S94 is also conserved in Yki 
and mutation of the corresponding S97 abolishes Yki-sd interaction13. Therefore, we 
propose that TAZ and Yki could be similarly regulated by AMPK in response to energy 
stress, suggesting an evolutionary conserved mechanism of Hippo pathway regulation by 
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cellular energy status. Our model also indicates that stress-induced AMPK activation can 
inhibit YAP even in the absence of Lats, providing an additional layer of YAP regulation. 
Consistent with this notion, AMPK activation inhibits tumorigenesis in Lats1/2 KO cells.
It is worth noting that AMPK can phosphorylate YAP on additional residues, such as S366 
and S463. In the accompanying paper from Dr. Chen and colleagues, AMPK-mediated 
phosphorylation of YAP on S61 inhibits YAP activity51. We did not identify S61 as an 
AMPK phosphorylation site because YAP-5SA mutant, of which S61 was already replaced 
by an alanine, was used in our in vitro experiments to map the AMPK phosphorylation sites 
in YAP. However, consistent with the data by Chen and colleagues, we noticed that energy 
starvation induced a much more dramatic mobility shift of YAP than the YAP-5SA mutant, 
supporting YAP S61 as one of the AMPK phosphorylation sites. We propose that AMPK 
has multiple mechanisms to regulate YAP activity in response to varying degrees of energy 
stress (Fig. 7e). Further evidence supporting a physiological function of the Hippo pathway 
in cellular energy response is the observation that AMPK activity was dramatically elevated 
in Lats KO cells (Fig. 3a), indicating that the Lats KO cells are under constant energy stress. 
Therefore, Lats is likely to play a role in cellular energy homeostasis. Energy stress-induced 
Lats activation reduces energy expenditure and cell growth, possibly by inhibiting YAP. Our 
study provides a mechanism of signal integration and crosstalk at YAP through multiple 
mechanisms of regulation.
Considering the general role of YAP in promoting cell proliferation and inhibiting apoptosis, 
it is not surprising that YAP activity is negatively regulated by cellular energy stress. When 
the Hippo pathway is inhibited under favorable conditions of low cell density and high 
serum (or hormonal signals), such conditions would normally allow YAP activation and cell 
growth. However, cell proliferation should not proceed if cellular energy is limited. 
Therefore, the direct inhibition of YAP by AMPK provides a mechanism to ensure that cell 
proliferation occurs only when favorable growth conditions are available. YAP inhibition by 
AMPK adds new dimensions to both physiological regulation of YAP and the biology of 
AMPK in cell growth control. Inhibition of YAP may contribute to the growth inhibitory 
and tumor suppressing activity of AMPK. Indeed, metformin has significant benefit of 
reducing tumor incidence and is the most prescribed among all drugs 37. Inhibition of YAP 
may contribute to the tumor inhibitory effect of metformin. Thus, pharmacological 
activation of AMPK may offer a potential therapeutic benefit for cancers with high YAP 
activity, even in tumors with diminished Lats activity.
METHODS
Antibodies and reagents
Anti-CTGF (sc-14939, 1:500), Cyr61 (sc-13100, 1:500) and donkey anti-goat IgG HRP 
Santa Cruz (sc-2020, 1:5,000) antibodies were obtained from Santa Cruz Biotechnology. 
Anti-YAP (#4912, 1:1,000), phospho-YAP (S127) (#4911, 1:1,000) TAZ (#4883, 1:1,000), 
Lats1 (#3477, 1:1,000), phospho-Lats1/2 (S909/872) (#9157, 1:1,000), phospho-Lats1/2 
(T1079/999) (#9159, 1:1,000), MST1 (#3682, 1:1,000), phospho-MST1/2 (T183/180) 
(#3681, 1:1,000), AMPKα (#2532, 1:1,000) phospho-AMPKα (T172) (#2535, 1:1,000), 
ACC (#3676, 1:1,000) and phospho-ACC (S79) (#3661, 1:1,000) were obtained from Cell 
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Signaling. Anti-Lats1 (A300-378A, 1:500) and YAP (A302-309A, 1:500) were obtained 
from Bethyl Laboratory. Anti-α-Vinculin (V9131, 1:2,000) was obtained from Sigma-
Aldrich. Anti-TEF (TEAD1) (610922, 1:500) was from BD Biosciences. Actin (ab3280, 
1:5,000) was obtained from Abcam (Cambridge, MA). Alexa Fluor 555-conjugated 
secondary antibody (A31572, 1:1,000) and Alexa Fluor® 488 Goat Anti-Rabbit IgG (H+L) 
Antibody (A11008, 1:1,000) were obtained from Invitrogen. Horseradish peroxidase 
conjugated secondary antibodies (NA931V and NA934V, 1:5,000) were obtained from GE 
Healthcare. Monoclonal ANTI-FLAG® M2-Peroxidase (HRP) antibody (A8592, 1:5,000) 
was obtained from Sigma-Aldrich. HA-Tag (6E2) mouse (HRP Conjugate) (#2999, 1:5,000) 
antibody was obtained from Cell Signaling. Anti-phosphorylated S94 antibody was 
generated by immunizing rabbits with phosphopeptides (Abbiotec and Gentex, 1:500). The 
phospho-specific antibodies were affinity purified. Phos-tag conjugated acrylamide was 
purchased from Wako chemicals. The following chemicals were used in this study: AICAR 
(#2840), Metformin hydrochloride (#2864), and A769662 (#3336) were purchased from 
TOCRIS and Toronto research chemicals. 2-Deoxy-D-glucose (D8375) was purchased from 
Sigma-Aldrich. Recombinant AMPK α/β/γ complex was purchased from GenScript. 
Mutagenesis was performed based on Quick-Change mutagenesis (Stratagene).
Cell culture and transfection
HEK293A, HEK293P, HEK293T, H2.35, NIH3T3, C2C12, and HeLa cells were cultured at 
37 °C in Dulbecco’s modified Eagle’s medium (DMEM) with 10% fetal bovine serum 
(FBS) (Invitrogen) and 50 µg/ml penicillin/streptomycin in a humidified incubator with 5% 
CO2. MCF10A cells were cultured in DMEM/F12 supplemented with 5% horse serum, 20 
ng/ml EGF, 0.5 µg/ml hydrocortisone, 10 µg/ml insulin, 100 ng/ml cholera toxin, and 50 
µg/ml penicillin/streptomycin. HepG2 cells were cultured in RPMI1640 supplemented with 
10% FBS and 50 µg/ml penicillin/streptomycin. For glucose starvation, cells were washed 
twice with PBS and then incubated in DMEM without glucose and pyruvate (0 g/L glucose, 
0 mM pyruvate; Invitrogen) supplemented with 10% FBS, Dialyzed (Invitrogen). Lats1 KO 
MEF cells, provided by Dr. Dae-SiK Lim (Korea Advanced Institute of Science and 
Technology), were maintained in DMEM with 10% FBS 39. AMPKα WT and AMPKα 
DKO MEFs, a gift from Dr. Benoit Viollet, were cultured in DMEM medium with 10% 
FBS 40. PolyJet™ DNA In Vitro Tranfection reagent (SignaGen Lab.) was used for 
transfection. siRNAs were synthesized by Dharmacon and delivered into cells using 
RNAiMAX (Invitrogen) according to manufacturer’s instructions.
PCR Genotyping
The genomic DNA was extracted from AMPKα WT and DKO MEFs and genotyped by 
PCR. Independent PCR reactions were assembled for each allele. Detection of AMPKα1 
wild-type allele used a sense primer (5’- AGCACAGTACCTGGTATCTTATAGG -3’) and 
AMPKα1 KO allele used a sense primer (5’- ACCAGAAGCGGTGCCGGAAAGCTGG 
-3’). The antisense primers were specific for the AMPKα1 wild-type allele (5’- 
GGACTTATTACTAAACAGACCTCTG -3’) and the AMPKα1 knockout allele (5’- 
TGTAGTCGGTTTATGCAGCAACGAG -3’). In the case of AMPKα2, the sense primers 
used were (5′- GCTTAGCACGTTACCCTGGATGG -3′) for the wild-type allele and (5′- 
GTTTGTGCTTATCTACTTTGTTTCC -3′) for the AMPKα 1 KO allele. The antisense 
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primers were (5′- GTCTTCACTGAAATACATAGCA -3′) for the wild-type and (5′- 
TGTGCTTCCTAACTGCAGATGCAGTG -3′) for AMPKα 1 KO allele. The PCR 
genotyping was performed with 5ng genomic gDNAs, 3mM each primer, and Biopioneer 
2xPCR mastermix according to the manufacture’s instruction. DNA bands were separated in 
a 1% agarose gel, being the sizes of about 329bp for AMPKα1 WT allele, 466bp for 
AMPKα1 KO allele, 260bp for AMPKα2 WT allele and 600 bp for AMPKα2 KO alleles, 
respectively.
Mass spectrometry
Samples were run 1cm into an 8–16% SDS-PAGE gel and gel slices excised. A gel band 
corresponding to the GST-YAP2 fusion protein was cut from a SDS–PAGE gel after an in 
vitro kinase reaction. Proteins in the gel were subjected to in-gel trypsin digestion. The first 
digested the sample with trypsin and then the extracted peptides are splited into two 
fractions. One of the those fractions was further digested with thermolysin, a non specific 
protease. The resulting peptide mixture was subjected Liquid chromatography tandem-mass 
spectrometry (LC-MS/MS) (Fred Hutchinson Cancer Research Center Proteomics facility). 
The mass spectrometry data were analyzed by Proteome Discover. Next the 
phosphopeptides that were identified, were analyzed by a program called PhosphoRS to 
determine site localization confidence.
Lambda phosphatase treatment
To evaluate the effects of phosphorylation on YAP, the AMPKa WT and DKO cells were 
treated with 2-DG (1 h) and then harvested.cells were lysed with mild lysis buffer (50 mM 
HEPES at pH 7.5, 150 mM NaCl, 1% NP-40, 10 mM pyrophosphate, 10 mM 
glycerophosphate, 50 mM NaF and protease inhibitor cocktail [Roche]), and centrifuged at 
12,000 × g for 15 min at 4 °C. The supernatants were incubated with either 5U lambda 
phosphatase (NEB) in the phosphatase buffer
Primary hepatocyte isolation
Mouse primary hepatocytes were isolated according to a method described in 46 with 
modifications. Briefly, under the perfusion, liver was washed in Ca2+ and Mg2+-free EBSS 
(Invitrogen) with 0.1 mM EGTA and 0.1 mM EDTA, and then digested with HBSS buffer 
(Invitrogen) containing 0.5 mg/ml collagenase IV and 0.5 mg/ml trypsin inhibitor (Roche). 
The perfused liver was dispersed and washed with DMEM. Hepatocytes were purified from 
the liver cells by gradient centrifugation in 50% Percoll (Invitrogen), and washed with 
DMEM. 1×106 hepatocytes were seeded onto each well of 6 well plates in DMEM 
supplemented with 10% FBS. William Medium E (Invitrogen) was used for the subsequent 
culture.
Retrovirus infection and stable cell lines
To generate TEAD1ΔC-YAP-AD expressing stable cells, retrovirus infection was performed 
by transfecting 293 Phoenix retrovirus packaging cells with pPGS empty vector or 
TEAD1ΔC-YAP(AD); TEAD1-ΔC (1–289) fused with the YAP C-terminal activation 
domain (290–488) construct. After transfection (48 hr), retroviral supernatant was filtered 
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through a 0.45-µm syringe filter, and used to infect Lats1/2 DKO MEFs in the presence of 
polybrene (10 µg/ml, Sigma-Aldrich). Infected cells were selected using G418 (VWR) or 
hygromycin (Invotrogen) in the culture medium.
Western Blot and immunoprecipitation
Immunoblotting was performed using a standard protocol. The phos-tag reagents were 
purchased from Wako Chemicals, and gels containing phos-tag were prepared according to 
the manufacture’s instructions. For immunoprecipitation, cells were lysed with mild lysis 
buffer (50 mM HEPES at pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% NP-40, 10 mM 
pyrophosphate, 10 mM glycerophosphate, 50 mM NaF, 1.5 mM Na3VO4, 1 mM PMSF, 1 
mM DTT, protease inhibitor cocktail [Roche]), and centrifuged at 12,000 × g for 15 min at 4 
°C. The supernatants were incubated with the appropriate antibodies for 2 hr at 4 °C, and 
protein G or protein A conjugated beads were added in for additional 1 hr. 
Immunoprecipitates were collected by centrifugation and washed four times with lysis 
buffer, and proteins were eluted with SDS-PAGE sample buffer.
Preparation of recombinant protein
Escherichia coli BL21 were transformed with bacterial expression constructs (pGEX-KG) 
containing the indicated genes. The expression of the recombinant GST-fusion proteins 
within the transformed bacteria was induced by using 0.5 mM isopropyl-β-D-
thiogalactopyranoside (IPTG) at 18 °C. Cells were re-suspended in PBS containing 0.5% 
Triton X-100, 1 mM PMSF and 2 mM β-mercaptoethanol, followed by ultrasonication. The 
proteins were purified by a single step using glutathione bead according to the 
manufacturer's protocol (Amersham Bioscience). Purified proteins were dialyzed against 20 
mM Tris at pH 8.0, and 10% glycerol. Purified GST–YAP protein (0.5 µg) was used for 
each AMPK assay.
In vitro kinase assay
To analyze kinase activity, HEK293A cells were harvested and lysed with lysis buffer (50 
mM HEPES at pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% NP-40, 10 mM pyrophosphoate, 
10 mM glycerophosphate, 50 mM NaF, 1.5 mM Na3VO4, protease inhibitor cocktail 
[Roche], 1 mM DTT, 1 mM PMSF) and immunoprecipitated with anti-indicated antibodies. 
The immunoprecipitates were washed three times with lysis buffer, followed by once with 
wash buffer (40 mM HEPES, 200 mM NaCl) and once with kinase assay buffer (30 mM 
HEPES, 50 mM potassium acetate, 5 mM MgCl2). The immunoprecipitated Lats1 was 
subjected to a kinase assay in the presence of GST-YAP fusion proteins as substrate. 
Phosphorylation of YAP was detected by phospho-YAP (S127) antibody. For AMPK kinase 
assays, purified YAP proteins were incubated with recombinant AMPK α1/β1/γ1 proteins 
(GenScript). The reaction mixtures were incubated for 30 min at 30°C, terminated with SDS 
sample buffer, and subjected to SDS-PAGE. Phosphorylation of YAP was determined by 
phospho-YAP (S94) antibody and 32P-autoradiography.
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shRNA
YAP (TRCN0000300325), TAZ (TRCN0000319150) and control shRNA were from Sigma-
Aldrich (St. Louis, MO). pMD2.G and psPAX2 were used to produce lentivirus in 293T 
cells.
siRNA
ON-TARGET plus SMARTpool siRNA oligonucleotides targeting mouse AMPKa1 and 
AMPKa2 were used (Dharmacon). A nontargeting scrambled siRNA duplex was used as a 
negative control (5’-CCAUUCCGAUCCUGAUCCG-3’) and introduced into cells by 
transient transfection with RNAiMAX (Invitrogen), in accordance with the manufacturer’s 
instructions
Immunofluorescence Staining
HEK293A cells were seeded on coverslips to appropriate density. After 2-DG treatment, 
cells were fixed with 4% paraformaldehyde-phosphate buffered saline (PBS) for 15 min and 
permeabilized with 0.1% Triton X-100 in PBS. After blocking in 2% goat serum and 2% 
BSA in TBS-T for 30min, cells were incubated with primary antibody diluted in 1% BSA 
for 1.5 hr. Primary antibodies used were YAP (H-125) from Santa Cruz. After three washes 
with TBS-T, cells were incubated with Alexa Fluor 488- secondary antibodies (Invitrogen, 
1:1000 dilution) for 1hr at room temperature. Slides were then washed three times and 
mounted with ProLong Gold antifade mountant with DAPI. The stained cells were detected 
using Olympus FV1000 confocal microscopy. The final images were obtained and analyzed 
by using confocal microscopy with FLUOVIEW viewer software. Each image is a single Z 
section at the same cellular level.
Luciferase assay
For luciferase reporter assay, HEK293-T cells were seeded in 12 well plates. Gal4-TEAD1, 
5×UAS-Luc reporter, pGL3-CTGF-Luc reporter, pRL reporter and indicated plasmids were 
co-transfected. After transfection (48 hr), cells were lysed and luciferase activity was 
assayed using the enhanced luciferase assay kit (Promega) following the manufacturer’s 
instructions. The firefly luciferase activity levels were measured and normalized to Renilla 
luciferase activity.
Soft agar assay
Each 6-well plate (ultra low attachment) was coated with 2 ml of bottom agar (DMEM 
containing 10% FBS and 0.7% Difco agar noble). Various Lats1/2 DKO MEFs (3×103 cells) 
were suspended in 1.5 ml of top agar (DMEM containing 10% FBS and 0.4% Difco agar 
noble) into each well. Cells were incubated for 3 weeks and replaced with fresh medium 
every three days. Colonies were stained using 0.05% crystal violet.
RNA isolation and real-time PCR
Cells were washed with cold PBS and total RNA was extracted using an RNesay kit 
(Qiagen) treated with RNA-free DNase. 1 µg of RNA was used for reverse transcription 
with iScript reverse transcriptase (Bio-Rad). cDNA was then diluted and used for real-time 
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PCR with gene-specific primers using KAPA SYBR FAST qPCR master mix (Kapa 
Biosystems) and the 7300 real-time PCR system (Applied biosystems). Relative abundance 
of mRNA was calculated by normalization to HPRT mRNA. Primers are described in;
HPRT AGAATGTCTTGATTGTGGAAGA/ ACCTTGACCATCTTTGGATTA
CTGF: CCAATGACAACGCCTCCTG/ TGGTGCAGCCAGAAAGCTC
CYR61: AGCCTCGCATCCTATACAACC/ TTCTTTCACAAGGCGGCACTC
Hprt GCAGTACAGCCCCAAAATGG/ ACAAAGTCCGGCCTGTATCCAA
Ctgf: CAA GGA CCG CAC AGC AGT T/ AGA ACA GGC GCT CCA CTC TG
Cyr61: GCTCAGTCAGAAGGCAGACC/ GTTCTTGGGGACACAGAGGA
Xenograft
Nude mice were provided by the UCSD animal core facility and housed in pathogen-free 
room with 12 hr light/dark cycle. A total of 1 × 106 cells were inoculated into 8 weeks old 
male nude mice by s.c. injection. After tumor size reaches 2 mm in diameter, the mice were 
randomly divided into two groups with eight animals. One group was treated with 
metformin at a dose of 250 mg/kg dayly, and the other group was treated with equal volume 
of PBS by i.p. injection. 15 days after the first metformin treatment, the mice were 
euthanized and the tumors were weighed. All the procedures followed the UCSD animal 
care guidelines.
Statistical analysis
Each experiment was repeated two or three times as mentioned in each figure legend. Data 
are presented as mean ± s.e.m. All statistical tests were performed using Student’s t-test 
(unpaired, two-tailed), *P<0.05, **P<0.01, ***P<0.001. No statistical method was used to 
predetermine sample size. Investigator were blinded to allocation during experiments and 
outcome assessment.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Cellular energy starvation activates Lats and inhibits YAP
(a) Glucose starvation induces YAP phosphorylation. HEK293A cells were starved of 
glucose as indicated for 1 hr. Cell lysates were prepared and subjected to immunoblotting 
for the indicated proteins and phosphorylation. Phos-tag denotes phos-tag gel used to resolve 
phosphorylated YAP based on mobility shift. Vin stands for vinculin as a loading control. 
Protein molecular markers are labeled on the right of each panel. (b) 2-DG induces YAP 
phosphorylation. HEK293A cells were treated with different doses of 2-DG in glucose-rich 
(25 mM) or glucose-free (0 mM) DMEM medium for 1 hr. Cell lysates were immunoblotted 
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with anti-AMP-activated protein kinase α (AMPKα), anti-pAMPKα (T172), anti-Acetyl-
CoA Carboxylase (ACC), and anti-pACC (S79). Both pAMPKα and pACC were analyzed 
as indicators of energy starvation. Experiments were similar to panel a. (c) 2-DG decreases 
YAP nuclear localization. HEK293A cells were treated with 25 mM 2-DG for 1 hr. YAP 
subcellular localization was determined by immunofluorescence staining for endogenous 
YAP (green); DAPI (blue) was used to stain cell nuclei. Scale Bars, 10µm. (d) 2-DG 
disrupts the interaction between YAP and TEAD1. Cells were treated with 25 mM 2-DG for 
2 hr as indicated. Cell lysates were precipitated with YAP or IgG control antibody. Co-
immunoprecipitation of TEAD was detected by Western blot. (e) 2-DG inhibits YAP target 
gene expression. HEK293A cells were treated with 10 mM and 25 mM 2-DG for 4 hr, 
mRNA levels of CTGF and CYR61 were measured by quantitative RT-PCR and normalized 
to HPRT control (error bars represent ± s.e.m. from n=3 independent experiments). (f) 
Energy stress increased Lats1 phosphorylation. HEK293A cells were treated with 25 mM 2-
DG for 1 hr. Endogenous Lats1 was immunoprecipitated and phosphorylation of the 
activation loop and hydrophobic motif was detected by Western blot with phosphospecific 
antibodies. (g) Glucose starvation activates Lats1 kinase activity. Cells were treated with 
glucose starvation for 1 hr. Lats1 was immunoprecipitated and in vitro kinase assays were 
performed using recombinant GST-YAP as the substrate. Phosphorylation of GST-YAP was 
determined by immunoblotting with the phospho-YAP (S127) antibody. All blots and 
immunofluorescence shown; are representatives of three independent experiments. 
Uncropped blots are shown in Supplementary Fig. 5. ***P<0.001, two-tailed t-test.
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Figure 2. AMPK is required for Hippo-YAP regulation by energy stress
(a) The 2-DG-induced YAP phosphorylation depends on AMPK. AMPKα WT and AMPKα 
DKO MEFs were treated with 25 mM 2-DG for the indicated durations. YAP 
phosphorylation is determined by phos-tag gel. (b) AMPK induces YAP phosphorylation. 
HEK293A cells were transiently co-transfected with the indicated plasmids as labeled on top 
of the lanes. Wild type AMPKα (AMPKα WT), but not the kinase-inactive AMPKα 
(AMPKα DN) increased YAP phosphorylation. (c) AMPK is required for Lats1 activation 
by energy stress. AMPKα WT and AMPKα DKO MEFs were incubated with or without 25 
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mM 2-DG for 2 hr. Endogenous Lats1 was immunoprecipitated and phosphorylation in both 
activation loop and the hydrophobic motif was detected by Western blot. (d) AMPK disrupts 
YAP and TEAD1 interaction. HEK293A cells were transiently co-transfected with the 
indicated plasmids. Flag-YAP was immunoprecipitated and the co-immunoprecipitated 
Myc-TEAD1 was detected by Myc Western blot. (e) AMPK inhibits the TEAD reporter. A 
luciferase reporter controlled by multiple TEAD binding sequences was transfected in to 
HEK293A cells together with AMPKα WT or AMPKα DN. After 48 hr, the firefly 
luciferase activity was measured and normalized to the co-transfected Renilla luciferase 
internal control (error bars represent ± s.e.m. from n=6 biological replicates). (f) Metformin 
activates AMPK and increases YAP phosphorylation. Primary mouse hepatocytes were 
treated with different doses of metformin for 4 or 8 hr. Phosphorylation of YAP and AMPK 
were measured by Western blot. TAZ phosphorylation was indicated by a mobility shift. (g) 
AICAR disrupts YAP and TEAD interaction. Primary mouse hepatocytes were treated with 
2 mM AICAR for 4 hr. The endogenous YAP was immunoprecipitated and the co-
precipitated TEAD was detected by Western blot. (h) AICAR and metformin inhibits YAP 
target gene expression. Primary mouse hepatocytes were treated with 2 mM AICAR or 2 
mM metformin for 4 hr, mRNA levels of Ctgf and Cyr61 were measured by quantitative 
RT-PCR (error bars represent ± s.e.m. from n=3 independent experiments). All experiments 
are representatives of three independent experiments except panel e. *P<0.05, **P<0.01, 
two-tailed t-test.
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Figure 3. Energy stress induces YAP phosphorylation via both Lats dependent and independent 
mechanisms
(a) Deletion of Lats1/2 diminishes, but not completely abolishes YAP phosphorylation by 2-
DG. Lats1−/−;Lats2fl/fl (denoted as Lats1 KO) MEFs and Cre- transduced Lats1−/−;Lats2fl/fl 
(denoted as Lst1/2 DKO) MEFs were treated with 10 and 25 mM 2-DG. YAP 
phosphorylation was detected by phospho-YAP (S127) antibody and phos-tag gel. Lats2 
deletion was confirmed by Western blot. All lysates were run on the same gel and the 
vertical line in YAP phos-tag blot indicated different exposures of the same Western Blot 
(the YAP phos-tag blot of Lats1/2 DKO samples was exposed shorter due to high YAP 
protein levels in these samples). (b) Overexpressed of kinase-inactive Lats2 (Lats2-KR) 
abolishes 2-DG-induced S127 phosphorylation, but not total phosphorylation, in YAP. Flag-
YAP was co-transfected with Lats2-WT or Lats2-KR mutant. After transfection, cells were 
treated with 25 mM 2-DG for 1 hr. (c) AMPK induces mobility shift of YAP-5SA. Flag-
YAP-5SA was co-transfected with AMPKα WT or AMPKα DN in HEK293A as indicated. 
(d, e) 2-DG stimulates the interaction of YAP and AMPKα. HEK293A cells transfected 
with the indicated plasmids were immunoprecipitated with anti-FLAG (for Flag-YAP) or 
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anti-HA (for HA-AMPK) and blotted with indicated antibodies for co-immunoprecipitation. 
(f) AICAR or Metformin promotes the association between endogenous AMPK and YAP. 
H2.35 cells were treated with AICAR or metformin. Cell lysates were immunoprecipitated 
with YAP or control IgG and Western blotted with AMPKα. All experiments are 
representatives of three independent experiments except panel e and f. The experiments in e, 
f were performed two times with similar results.
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Figure 4. AMPK phosphorylates S94 in YAP
(a) AMPK directly phosphorylates YAP in vitro. The indicated various YAP mutant 
proteins were purified from E.coli and used as substrates for in vitro phosphorylation by 
AMPK. Phosphorylation was determined by 32P-autoradiography and the amount of each 
GST-YAP protein was detected by coomassie staining. (b) Confirmation of AMPK 
phosphorylation sites in YAP by mutagenesis. Schematic representation of YAP domains 
and deletion constructs used to map phosphorylation sites are shown on the top. The human 
YAP protein contains a TEAD Binding Domain (TBD; residues 48–102), two WW domains 
(WW1, 171–204; WW2, 230–263) domains and an Activation Domain (AD; 292–488). 
Three different YAP deletion constructs and multiple amino acid mutations in these YAP 
truncations were expressed, purified, and used as substrates for in vitro AMPK 
phosphorylation in the presence of 32P-ATP. Phosphorylation was detected by 
autoradiography. GST-YAP fragment protein was detected by Coomassie staining.
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Figure 5. AMPK inhibits YAP activity through phosphorylation of serine 94
(a) Phosphomimetic mutant of YAP S94 abolishes YAP activity. The indicated plasmids 
were co-transfected with a 5×UAS-luciferase reporter for Gal4-TEAD4 and Renilla 
construct into HEK293T cells. The firefly luciferase activity levels were measured and 
normalized to Renilla luciferase activity levels (error bars represent ± s.e.m. from n=6 
biological replicates). (b) S94 is important for YAP activity and inhibition by AMPK. All 
three AMPK phosphorylation sites in YAP were mutated to alanine. The YAP plasmids 
were co-transfected with the 5xUAS-luciferase reporter for Gal4-TEAD4 into HEK293T 
cells together with the control Renilla luciferase. After 48 hr, the firefly luciferase activity 
was measured and normalized to the co-transfected Renilla luciferase internal control (error 
bars represent ± s.e.m. from n=6 biological replicates). (c) S94 of YAP is essential for 2-
DG-induced disruption of YAP-TEAD complex. HEK293A cells were transiently co-
transfected with the indicated plasmids followed by treatment with 2-DG. Interaction 
between Flag-YAP and Myc-TEAD4 was determined by co-immunoprecipitation. (d) 
Evaluation of phospho-specific antibodies for YAP S94 phosphorylation. Phosphoantibody 
was prepared by immunizing rabbits with synthetic phosphopeptides containing phospho-
YAP S94. Recombinant GST-YAP (51–270) fragment was purified from bacteria and 
phosphorylated by AMPK in vitro. After the reaction, 5 ng of the GST-YAP protein was 
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detected by phospho-YAP S94 or GST antibody. The non-phosphorylatable mutant, GST-
YAP-S94A was used as a negative control. (e) AMPK increases YAP S94 phosphorylation 
in transfected cells. Flag-YAP WT and YAP-S94A mutant were transfected into HEK293 
cells with or without AMPK as indicated. Flag-YAP was immunoprecipitated and 
phosphorylation of S94 was detected by the pYAP(S94) phosphoantibody. (f) AICAR 
increases YAP S94 phosphorylation in vivo. Primary hepatocytes were treated with 2 mM 
AICAR for 4 hr. YAP was immunoprecipitated and phosphorylation of S94 was detected by 
the pYAP(S94) phosphoantibody. All blots shown are representatives from three 
independent experiments except panel e. **P<0.01, ***P<0.001, two-tailed t-test.
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Figure 6. Energy stress attenuates tumorigenecity of Lats1/2 DKO MEFs
(a) AICAR inhibits YAP target gene expression in Lats1/2 DKO MEFs. Lats1/2 DKO 
MEFs were treated with 0.5 mM and 1 mM of AICAR for 5 hr. mRNA levels of Ctgf and 
Cyr61 were measured by quantitative RT-PCR (error bars represent ± s.e.m. from n=3 
independent experiments). (b) Knockdown of YAP or TAZ attenuates anchorage-
independent growth of Lats1/2 DKO MEFs. YAP or TAZ was knockdown by shRNAs in 
Lats1/2 DKO MEFs (the experiments was repeated 2 times). The Lats1/2 DKO MEFs (3 × 
103 cells) were seeded onto a culture medium containing 0.3% agar and incubated at 37 °C 
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for 2 weeks. The colonies were stained with 0.005% crystal violet. (c) Energy stress 
attenuates anchorage-independent growth of Lats1/2 DKO MEFs. Lats1/2 DKO MEFs (3 × 
103 cells) were seeded onto a culture medium containing 0.3% agar and incubated at 37 °C 
for 2 weeks. The colonies were stained with 0.005% crystal violet and quantified. AICAR 
and metformin treatments were indicated (error bars represent ± s.e.m. from n=3 
independent experiments). (d) Metformin inhibits tumor growth of Lats1/2 DKO MEFs in 
xenografted mice. Mice were ectopically implanted with 1x106 cells on the both sides of 
each mouse. Daily i.p. injection of 250mg/kg dose of Metformin or equal volume (300µL) of 
vehicle (PBS) for 15 days. At the end of the experiment, mice were sacrificed 16 days after 
implantation and tumor weight was measured (error bars represent ± s.e.m. from 8 tumors (4 
mice) per group). Scale bar, 1cm. *P<0.05, two-tailed t-test.
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Figure 7. AMPK is required for energy stress to inhibit YAP activity
(a) AMPK is required for inhibition of Ctgf and Cry61 by AICAR. Lats1/2 DKO MEFs 
were transfected with control or AMPK siRNAs. The knockdown efficiency of AMPK was 
confirmed by Western blot (left panels). After treating with the AMPK activator AICAR 
(0.5 mM), mRNA levels of Ctgf and Cyr61 were measured by quantitative RT-PCR. The 
mRNA relative unit values are normalized to 1 (controls without AICAR treatment) (the 
experiments was repeated 2 times). (b) Lats1/2 DKO MEFs were transiently transfected 
with control (siCon) or AMPK (siAMPKa) siRNA. After treating with the AMPK activator 
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A769662 (0.3mM for 4 hr), mRNA levels of Ctgf and Cyr61 were measured by quantitative 
RT-PCR (the experiments was repeated 2 times). (c) AICAR cannot inhibit YAP target 
genes in cells expressing TEAD1ΔC-YAP(AD). HA-TEAD1ΔC-YAP(AD), which is a 
fusion of the TEAD DNA binding domain with the YAP transactivation domain, was stably 
expressed in Lats1/2 DKO MEFs. Expression of HA- TEAD1ΔC-YAP(AD) was confirmed 
by Western blot. Cells were treated in AICAR as indicated and mRNA levels of Ctgf and 
Cyr61 were measured by quantitative RT-PCR (error bars represent ± s.e.m. from n=5 
independent experiments). (d) Expression of HA-TEAD1ΔC-YAP(AD) confers Lats1/2 
DKO MEFs resistant to growth inhibition by AMPK activators. Soft-agar colony-formation 
assay was performed with Lats1/2 DKO MEFs expressed with vector (top row) or HA- 
TEAD1ΔC-YAP(AD) (bottom row). Treatments with PBS control, AICAR, metformin, or 
A769662 are indicated. (e) A model for regulation of Hippo-YAP pathway by energy stress 
and AMPK. When the energy is sufficient, AMPK is inactive and YAP is active. When 
cellular energy level is low (energy stress), Both AMPK and Lats are active. The active 
AMPK and Lats inhibit YAP by phosphorylation.
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